SalMar Group's results show salmon disease impact
Thursday, August 16, 2012, 03:10 (GMT + 9)
The issues related to the appearance of pancreas disease (PD) virus had a negative impact in the results SalMar Group obtained in the second quarter of this year.
The group recorded an operational EBIT of NOK 59.9 million (EUR 8.2 million) in the second quarter 2012 compared with NOK 112.0 million (EUR 15.3 million) a year before. The firm generated gross operating revenues of NOK 836.7 million (EUR 114.3 million) in the second quarter 2012, compared with NOK 681.7 million (EUR 93.2 million) in the same quarter in 2011.
SalMar Central Norway's lower performance was affected by PD, as PD-related harvesting has bred higher costs for fish farming operations and affected InnovaMar's efficiency. The fish may not be destroyed, however, as the Norwegian Food Safety Authority (NFSA) has now changed its practice with respect to the handling of PD in Sør-Trøndelag.
Moreover, about half the volume was harvested in June, when salmon prices were lower than in April and May.